[PDF] Top 20 Rev. Bras. Hematol. Hemoter. vol.35 número4
Has 10000 "Rev. Bras. Hematol. Hemoter. vol.35 número4" found on our website. Below are the top 20 most common "Rev. Bras. Hematol. Hemoter. vol.35 número4".
Rev. Bras. Hematol. Hemoter. vol.35 número4
... “ Faced with the exclusion of the annual calculation of the impact factor in the 2012 Edition of the Journal Citation Reports of six important Brazilian journals due to anomalies identi[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.35 número4
... In the literature, many studies aim to exert greater control over the use of blood products. One study, performed by auditing the largest hospitals in Sydney, reported that during the irst audit, 35% of the ... See full document
5
Rev. Bras. Hematol. Hemoter. vol.35 número4
... 10. Ribeiro MA, Proietti FA, Martins ML, Januário JN, Ladeira RV, Oliveira M de F, et al. Geographic distribution of human T-lymphotropic virus types 1 and 2 among mothers of newborns tested during neonatal screening, ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.35 número4
... Figures 1 & 2 – Peripheral blood smear presenting numerous platelets adhered to mature granulocytes. consistent with platelet satellitism[r] ... See full document
1
Rev. Bras. Hematol. Hemoter. vol.35 número4
... N, Lambilliotte A, Aladjidi N, Bertrand Y, Mialou V, Perot C,Michel G, Fouyssac F, Paillard C, Gandemer V, Boutard P, Schmitz J, Morali A, Leblanc T, Bellanné-Chantelot C; Associated investigators of the French Severe ... See full document
3
Rev. Bras. Hematol. Hemoter. vol.35 número4
... Essential thrombocythemia is an acquired myeloproliferative disorder characterized by the proliferation of megakaryocytes in bone marrow, leading to a persistent increase in the number [r] ... See full document
3
Rev. Bras. Hematol. Hemoter. vol.35 número4
... 47. Visentainer JE, Sell AM, da Silva GC, Cavichioli AD, Franceschi DS, Lieber SR, et al. TNF, IFNG, IL6, IL10 and TGFB1 gene polymorphisms in South and Southeast Brazil. Int J Immunogenet. 2008;35(4-5):287-93. 48. ... See full document
7
Rev. Bras. Hematol. Hemoter. vol.35 número4
... = 35), MF (n = 11), PV (n = 10), blast-phase MPN (n = 5) and unclassiiable MPNs (n = 3), mutations of this gene in heterozygosis were identiied in ive JAK2V617F-negative ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.35 número4
... Objective: The aim of this exploratory, cross-sectional study was to evaluate pain in sickle cell disease patients and aspects related to primary healthcare.. Methods: Data were obtai[r] ... See full document
6
Rev. Bras. Hematol. Hemoter. vol.35 número4
... 1. Lima GM, Eustáquio JM, Martins RA, Josahkian JA, Pereira GA, Moraes- Souza H, et al. Declínio da prevalência do HTLV-1/2 em doadores de sangue do Hemocentro Regional da Cidade de Uberaba, Estado de Minas Gerais, 1995 ... See full document
4
Rev. Bras. Hematol. Hemoter. vol.35 número4
... The Objective: To investigate the incidence and risk factors of iniltration of the central nervous system after the initial treatment of diffuse large B-cell lymphoma in patients trea[r] ... See full document
7
Rev. Bras. Hematol. Hemoter. vol.35 número4
... combination of matching compatible antigens and the application of mismatch acceptability determined by serum screening for HLA antibodies has offered an effective approach for HLA-bas[r] ... See full document
4
Rev. Bras. Hematol. Hemoter. vol.35 número4
... Regarding patients submitted to hemodialysis, the sickle cell anemia population had similar scores for physical limitation, emotional aspect, social function and mental health[r] ... See full document
4
Rev. Bras. Hematol. Hemoter. vol.35 número4
... Alegre (Brazil) to assess the appropriateness of requests for blood products in three sectors of the hospital based on its protocol on care routines for blood component transfusions, f[r] ... See full document
3
Rev. Bras. Hematol. Hemoter. vol.35 número4
... Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin’s lymphoma uniformly treated and receiving intrathecal central nervous system prop[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.35 número4
... 6. Voskaridou E, Ladis V, Kattamis A, Hassapopoulou E, Economou M, Kourakli A, Maragkos K, Kontogianni K, Laioniatis S, Vrettou E, Koutsouka F, Papadakis A, Mihos A, Eftihiadis E, Farmaki K, Papageorgiou O, Tapaki G, ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.35 número4
... was obtained for HIV and HCV and they showed a 35% clearance rate for HCV and no elite controllers for HIV. The primary objective of the paper is to describe an unusual HBV yield case. This case tested HBsAg and ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.35 número4
... Nevertheless, prompted by the accompanying paper, we analyzed weekly blood collection data for the American Red Cross, which collects about 40% of the 14 million blood donations in the[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.35 número4
... looks speciically at the distribution of weekly blood collections at three major Brazilian blood centers participating in the Retrovirus Epidemiology Donor Study-II (REDS-II) r[r] ... See full document
2
Rev. Bras. Hematol. Hemoter. vol.35 número4
... 7. Bub CB, Martinelli BM, Avelino TM, Gonçalez AC, Barjas-Castro ML, Castro V. Platelet antibody detection by low cytometry: an effective method for evaluation and support in platelet refractoriness. Rev ... See full document
2
temas relacionados